Literature DB >> 1521215

Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board.

.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1521215      PMCID: PMC1336391     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  86 in total

1.  Geographical distribution of diabetes among the native population of Canada: a national survey.

Authors:  T K Young; E J Szathmary; S Evers; B Wheatley
Journal:  Soc Sci Med       Date:  1990       Impact factor: 4.634

Review 2.  Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension.

Authors:  M G Myers; S G Carruthers; F H Leenen; R B Haynes
Journal:  CMAJ       Date:  1989-05-15       Impact factor: 8.262

3.  Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.

Authors:  M S Wu; P Johnston; W H Sheu; C B Hollenbeck; C Y Jeng; I D Goldfine; Y D Chen; G M Reaven
Journal:  Diabetes Care       Date:  1990-01       Impact factor: 19.112

4.  Effect of pregnancy on progression of diabetic retinopathy.

Authors:  B E Klein; S E Moss; R Klein
Journal:  Diabetes Care       Date:  1990-01       Impact factor: 19.112

5.  A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates.

Authors:  N J Morrish; L K Stevens; J Head; J H Fuller; R J Jarrett; H Keen
Journal:  Diabetologia       Date:  1990-09       Impact factor: 10.122

6.  Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

Authors:  M C Riddle; J S Hart; D J Bouma; B E Phillipson; G Youker
Journal:  Diabetes Care       Date:  1989-10       Impact factor: 19.112

7.  Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide.

Authors:  V Trischitta; S Italia; V Borzi; A Tribulato; S Mazzarino; S Squatrito; R Vigneri
Journal:  Diabetes Care       Date:  1989-09       Impact factor: 19.112

8.  Decline in the risk of myocardial infarction among women who stop smoking.

Authors:  L Rosenberg; J R Palmer; S Shapiro
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

9.  Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking.

Authors:  C S Moy; R E LaPorte; J S Dorman; T J Songer; T J Orchard; L H Kuller; D J Becker; A L Drash
Journal:  Circulation       Date:  1990-07       Impact factor: 29.690

10.  Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood.

Authors:  M B Max; M Culnane; S C Schafer; R H Gracely; D J Walther; B Smoller; R Dubner
Journal:  Neurology       Date:  1987-04       Impact factor: 9.910

View more
  6 in total

1.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

2.  Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis.

Authors:  David Maberley; Hugh Walker; Anita Koushik; Alan Cruess
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

3.  Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines.

Authors:  Cory Russell; Peggy Dunbar; Sonia Salisbury; Ingrid Sketris; George Kephart
Journal:  Cardiovasc Diabetol       Date:  2005-07-20       Impact factor: 9.951

4.  Insulin glargine overdose.

Authors:  Fatma Sarı Doğan; Ozge Ecmel Onur; Arzu Denizbaşı Altınok; Ozlem Göneysel
Journal:  J Pharmacol Pharmacother       Date:  2012-10

5.  Guidelines for the management of diabetic patients in the health centers of saudi arabia.

Authors:  E A Al-Faris
Journal:  J Family Community Med       Date:  1997-01

6.  Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study.

Authors:  Sarah E Wilson; Lorraine L Lipscombe; Laura C Rosella; Douglas G Manuel
Journal:  BMC Health Serv Res       Date:  2009-02-27       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.